EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments

Arron Aatkar, Aini Vuorinen, Oliver E Longfield, Katharine Gilbert, Rachel Peltier-Heap, Craig D Wagner, Francesca Zappacosta, Katrin Rittinger iD, Chun-Wa Chung iD, David House iD, Nicholas C O Tomkinson iD, Jacob T Bush iD

ACS Chemical Biology · 2023

DOI: 10.1021/acschembio.3c00034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2023. Verfasst von Arron Aatkar und 11 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K. Hauptthemen laut MEDLINE: Cysteine, Fluorides. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sulfur(VI) fluorides (SFs) have emerged as valuable electrophiles for the design of "beyond-cysteine" covalent inhibitors and offer potential for expansion of the liganded proteome. Since SFs target a broad range of nucleophilic amino acids, they deliver an approach for the covalent modification of proteins without requirement for a proximal cysteine residue. Further to this, libraries of reactive fragments present an innovative approach for the discovery of ligands and tools for proteins of interest by leveraging a breadth of mass spectrometry analytical approaches. Herein, we report a screening approach that exploits the unique properties of SFs for this purpose. Libraries of SF-containing reactive fragments were synthesized, and a direct-to-biology workflow was taken to efficiently identify hit compounds for CAII and BCL6. The most promising hits were further characterized to establish the site(s) of covalent modification, modification kinetics, and target engagement in cells. Crystallography was used to gain a detailed molecular understanding of how these reactive fragments bind to their target. It is anticipated that this screening protocol can be used for the accelerated discovery of "beyond-cysteine" covalent inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CysteineFluoridesLigandsAmino AcidsSulfur

Substanzen

CysteineFluoridesLigandsAmino AcidsSulfur

Autor:innen und Institutionen

  • GSK, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
  • Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, U.K.
  • The Francis Crick Institute, London NW1 1AT, U.K.
  • GSK, South Collegeville Road, Collegeville, Pennsylvania 19426, United States.

ORCID-Profile: Katrin Rittinger, Chun-Wa Chung, David House, Nicholas C O Tomkinson, Jacob T Bush

Förderung

  • Cancer Research UK
  • Medical Research Council
  • Wellcome Trust
  • Engineering and Physical Sciences Research Council

Zitieren

APA

Aatkar, A., Vuorinen, A., Longfield, O. E., Gilbert, K., Peltier-Heap, R., Wagner, C. D., Zappacosta, F., Rittinger, K., Chung, C. W., House, D., Tomkinson, N. C. O., & Bush, J. T. (2023). Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00034

Vancouver

Aatkar A, Vuorinen A, Longfield OE, Gilbert K, Peltier-Heap R, Wagner CD, et al. Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments. ACS Chemical Biology. 2023. doi:10.1021/acschembio.3c00034

BibTeX
@article{Aatkar2023,
  author = {Aatkar, Arron and Vuorinen, Aini and Longfield, Oliver E and Gilbert, Katharine and Peltier-Heap, Rachel and Wagner, Craig D and Zappacosta, Francesca and Rittinger, Katrin and Chung, Chun-Wa and House, David and Tomkinson, Nicholas C O and Bush, Jacob T},
  title = {Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments},
  journal = {ACS Chemical Biology},
  year = {2023},
  doi = {10.1021/acschembio.3c00034}
}
Kostenlos starten →